Documents OHSU Updates in Hematology and Breast Cancer Conference CML ASH Update Michael J. Mauro, MD.

Slide 1 OHSU Updates in Hematology and Breast Cancer Conference CML ASH Update Michael J. Mauro, MD Slide 2 CML Abstracts Novel Agents Abstract # 109 : A Pivotal Phase 2…

Documents 1 Saglio G et al. Proc ASH 2011;Abstract 452. 2 Hughes TP et al. Proc ASH 2011;Abstract 606.

Nilotinib versus Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTnd 36-Month…

Documents OHSU Updates in Hematology and Breast Cancer Conference CML ASH Update

Title of Module/Lecture OHSU Updates in Hematology and Breast Cancer Conference CML ASH Update Michael J. Mauro, MD CML Abstracts Novel Agents Abstract # 109: A Pivotal Phase…

Documents Oncology Journal Club Addressing Imatinib-resistant CML

Oncology Journal Club Addressing Imatinib-resistant CML Frank Giles, MD, FRCPI, FRCPath Chief, Division of Hematology and Medical Oncology Director, Institute for Drug Development…